AGAP3 and Cryptococcal meningitis: Given that we only identified one CrAg positive participant with CD4 > 200 cells/mm3 who did not die or develop cryptococcal meningitis, we did not find any evidence to support raising the screening threshold to CD4 > 200 cells/mm3 in this setting.